Valuation: Instituto Rosenbusch S.A.

Market Cap 689.95Cr 46.24L 40.46L 37.29L 34.56L 65.61L 44Cr 66.67L 4.47Cr 1.74Cr 22Cr 1.74Cr 1.7Cr 75Cr P/E 2024
-3.67x
P/E 2025 -2.23x
Enterprise Value 763.72Cr 51.18L 44.79L 41.28L 38.26L 72.63L 49Cr 73.8L 4.95Cr 1.92Cr 24Cr 1.92Cr 1.88Cr 83Cr EV / Sales 2024
0.73x
EV / Sales 2025 1.71x
Free-Float
19.84%
Yield 2024 *
-
Yield 2025 -
1 day+2.53%
1 week-1.22%
Current month-0.61%
1 month+0.31%
3 months-14.96%
6 months-26.70%
Current year-32.64%
1 week 155
Extreme 155
165.5
1 month 155
Extreme 155
171.5
Current year 128.5
Extreme 128.5
260
1 year 116
Extreme 116
357
3 years 21
Extreme 21
450
5 years 9.1
Extreme 9.1
450
10 years 4.2
Extreme 4.2
450
Manager TitleAgeSince
Director of Finance/CFO - 30/07/2010
Chief Tech/Sci/R&D Officer - -
Chief Administrative Officer - -
Director TitleAgeSince
Chairman - 30/07/2010
Change 5-day change 1-year change 3-year change Capi.($)
+2.53%-1.22%+15.10%+636.36% 46.26L
+1.20%+5.52%-51.72%-54.63% 3.16TCr
-1.81%+0.22%+70.46%+145.67% 1.26TCr
-4.51%+1.26%-16.75%+0.25% 382.12Cr
+0.46%-1.80%-1.66%+30.60% 310.89Cr
-0.86%+6.58%+56.51%+32.81% 204.9Cr
-0.17%+3.25%-27.80%+18.24% 165.53Cr
-3.25%+5.89%+11.20%+131.71% 138.45Cr
-1.63%+5.85%-20.23%-9.49% 106.86Cr
+1.26%+2.26%-3.07%-17.33% 95Cr
Average -0.65%+1.54%+3.20%+91.42% 582.12Cr
Weighted average by Cap. -0.17%+1.97%-13.04%+7.78%

Financials

2024 2025
Net sales 827.49Cr 55.45L 48.53L 44.72L 41.45L 78.69L 53Cr 79.96L 5.36Cr 2.09Cr 26Cr 2.08Cr 2.04Cr 90Cr 640.36Cr 42.91L 37.55L 34.61L 32.08L 60.9L 41Cr 61.88L 4.15Cr 1.61Cr 20Cr 1.61Cr 1.58Cr 69Cr
Net income -141.73Cr -9L -8L -8L -7L -13.48L -9.01Cr -13.7L -91.85L -35.72L -4.45Cr -35.66L -34.89L -15Cr -459.77Cr -30.81L -26.96L -24.85L -23.03L -43.72L -29Cr -44.43L -2.98Cr -1.16Cr -14Cr -1.16Cr -1.13Cr -50Cr
Net Debt 86Cr 6L 5L 5L 4L 8L 5.49Cr 8L 55.94L 21.75L 2.71Cr 21.72L 21.25L 9.37Cr 74Cr 5L 4L 4L 4L 7L 4.69Cr 7L 47.81L 18.59L 2.32Cr 18.56L 18.16L 8Cr
Logo Instituto Rosenbusch S.A.
Instituto Rosenbusch SA de Biologia Experimental Agropecuaria is an Argentina-based company primarily engaged in the production and sale of such veterinary products as antiparasitic drugs, vitamins, hormone treatments and vaccines, among others. The Company's products are structured in two lines: Pharmaceutical, including antibiotics, antimastitics products, antimycotics, antiparasites, vitamins, minerals and other chemotherapies, and Biological, comprising vaccines for cattle, equines, porks and sheeps and dogs. It is also involved in the slaughtering and provision of meat products. As of December 31, 2011, the Company owned such subsidiaries as Laboratorios Rosenbusch SA, Laboratorios Bolivar SA and Rosenbusch Paraguay SA.
Employees
-
Date Price Change Volume
06/26/06 ARS 162.00 +2.53% 14,507
03/26/03 ARS 158.00 -3.07% 3,769
02/26/02 ARS 163.00 0.00% 9,583
01/26/01 ARS 163.00 0.00% 11,988
30/26/30 ARS 163.00 -0.61% 17,133
  1. Stock Market
  2. Stocks
  3. ROSE Stock